Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
11 . 03 . 2026
Press release
Latest press releases and news stories
Go to news archive
Featured News Article
11/03/2026
Press release
Galderma buys back shares worth CHF 232 million in the context of accelerated bookbuild offering
11/03/2026
Press release
Galderma completes successful placement of EUR 500 million Eurobond
10/03/2026
News story
Pioneering study deepens our understanding of sensitive skin
09/03/2026
Press release
Galderma introduces Cetaphil AM/PM Antioxidant Serums, a new science-driven defense and recovery system for sensitive skin
05/03/2026
Press release
Galderma delivers record 2025 results with net sales of 5.207 billion USD, up 17.7% at constant currency, and Core EBITDA of 1.211 billion USD, growing 18.9% at constant currency
GALDERMA'S RESPONSE TO AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
Discover key insights from the first international consensus guidelines in the full report.
Galderma Annual Reports
MEDIA TOOLKIT: ATOPIC DERMATITIS
Access materials for additional information about the burden of atopic dermatitis.
MEDIA TOOLKIT: PRURIGO NODULARIS
Access materials for additional information about the burden of prurigo nodularis.
MEDIA TOOLKIT: SENSITIVE SKIN AND MODERN LIFESTYLES
Galderma’s scientific response to a growing dermatological challenge.
MEDIA TOOLKIT: MEDICATION-DRIVEN WEIGHT LOSS
Understanding the aesthetic impacts of significant and rapid weight loss.
GET IN TOUCH WITH
25.08.2025
Press release
17.06.2025
Press release
